Loss of expression of STK11 / LKB1 in intratubular large cell hyalinizing Sertoli cell neoplasm
Histopathology · 2025
DOI: 10.1111/his.15513 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, 2025. Verfasst von William J Anderson und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Sertoli Cell Tumor, Protein Serine-Threonine Kinases, Biomarkers, Tumor, Testicular Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Aims
Intratubular large cell hyalinizing Sertoli cell neoplasia (ILCHSCN) is a rare testicular sex cord stromal tumour that occurs in paediatric patients in the context of Peutz‐Jeghers syndrome, a condition caused by germline STK11 alterations. The diagnosis of ILCHSCN and its distinction from large cell calcifying Sertoli cell tumour (LCCSCT), a neoplasm associated with loss of function PRKAR1A mutations, can be challenging. We therefore aimed to assess the immunohistochemical expression of STK11 in a cohort of ILCHSCN and LCCSCT to investigate its diagnostic utility. Methods and results Immunohistochemistry (IHC) for STK11 was assessed in 7 ILCHSCN and 9 LCCSCT. Six ILCHSCN were also stained for PRKAR1A, a biomarker known to be lost in LCCSCT. The majority of ILCHSCN (4/7; 57%), including one case with invasion, showed complete loss of expression of STK11. All LCCSCT (9/9) showed retained STK11 expression. All ILCHSCN assessed with PRKAR1A (6/6) showed retained expression.
Conclusions
The majority of ILCHSCN demonstrate loss of expression of STK11, while LCCSCT shows retained expression. Our findings support that STK11 IHC is highly specific and moderately sensitive in distinguishing between these two tumours. The combination of STK11 and PRKAR1A IHC has even greater utility for distinguishing ILCHSCN and LCCSCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Department of Pathology, La Paz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain.
- Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Department of Pathology, Douglass Hanly Moir Pathology, Macquarie University, Sydney, New South Wales, Australia.
ORCID-Profile: William J Anderson, David L Kolin, Sara O Vargas, Pilar Gonzalez-Peramato, Kristine M Cornejo, Fiona Maclean, Ankur R Sangoi, Maurizio Colecchia, Michelle S Hirsch, Thomas M Ulbright, Andres M Acosta
Zitieren
APA
Anderson, W. J., Kolin, D. L., Gonzalez, I. A., Vargas, S. O., Gonzalez-Peramato, P., Cornejo, K. M., Maclean, F., Sangoi, A. R., Colecchia, M., Hirsch, M. S., Ulbright, T. M., & Acosta, A. M. (2025). Loss of expression of STK11 / LKB1 in intratubular large cell hyalinizing Sertoli cell neoplasm. Histopathology. https://doi.org/10.1111/his.15513
Vancouver
Anderson WJ, Kolin DL, Gonzalez IA, Vargas SO, Gonzalez-Peramato P, Cornejo KM, et al. Loss of expression of STK11 / LKB1 in intratubular large cell hyalinizing Sertoli cell neoplasm. Histopathology. 2025. doi:10.1111/his.15513
BibTeX
@article{Anderson2025,
author = {Anderson, William J and Kolin, David L and Gonzalez, Ivan A and Vargas, Sara O and Gonzalez-Peramato, Pilar and Cornejo, Kristine M and Maclean, Fiona and Sangoi, Ankur R and Colecchia, Maurizio and Hirsch, Michelle S and Ulbright, Thomas M and Acosta, Andres M},
title = {Loss of expression of STK11 / LKB1 in intratubular large cell hyalinizing Sertoli cell neoplasm},
journal = {Histopathology},
year = {2025},
doi = {10.1111/his.15513}
}
EUVIMED